ArticleEMBO molecular medicine2014
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy.
John M L Ebos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it